UBS Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
671,284
-60,569
| -8% | -$969K | ﹤0.01% | 2367 |
|
|
2025
Q1 | $12.5M | Buy |
731,853
+141,089
| +24% | +$2.41M | ﹤0.01% | 2174 |
|
|
2024
Q4 | $14.6M | Buy |
590,764
+449,775
| +319% | +$11.1M | ﹤0.01% | 2026 |
|
|
2024
Q3 | $4.02M | Buy |
140,989
+21,634
| +18% | +$617K | ﹤0.01% | 2460 |
|
|
2024
Q2 | $3.15M | Sell |
119,355
-83,195
| -41% | -$2.2M | ﹤0.01% | 2470 |
|
|
2024
Q1 | $6.54M | Buy |
202,550
+47,468
| +31% | +$1.53M | ﹤0.01% | 1945 |
|
|
2023
Q4 | $6.53M | Buy |
155,082
+70,285
| +83% | +$2.96M | ﹤0.01% | 1758 |
|
|
2023
Q3 | $3.26M | Sell |
84,797
-7,138
| -8% | -$274K | ﹤0.01% | 2174 |
|
|
2023
Q2 | $1.74M | Sell |
91,935
-31,101
| -25% | -$590K | ﹤0.01% | 2814 |
|
|
2023
Q1 | $1.91M | Sell |
123,036
-30,839
| -20% | -$478K | ﹤0.01% | 2641 |
|
|
2022
Q4 | $2.73M | Buy |
153,875
+146,897
| +2,105% | +$2.61M | ﹤0.01% | 2305 |
|
|
2022
Q3 | $39K | Buy |
6,978
+4,695
| +206% | +$26.2K | ﹤0.01% | 5508 |
|
|
2022
Q2 | $9K | Buy |
+2,283
| New | +$9K | ﹤0.01% | 7099 |
|
|
2022
Q1 | – | Sell |
-166,534
| Closed | -$1.42M | – | 9360 |
|
|
2021
Q4 | $1.42M | Buy |
166,534
+117,796
| +242% | +$1M | ﹤0.01% | 3165 |
|
|
2021
Q3 | $423K | Buy |
48,738
+12,095
| +33% | +$105K | ﹤0.01% | 3833 |
|
|
2021
Q2 | $387K | Sell |
36,643
-46,487
| -56% | -$491K | ﹤0.01% | 3917 |
|
|
2021
Q1 | $1.33M | Buy |
83,130
+33,895
| +69% | +$544K | ﹤0.01% | 3095 |
|
|
2020
Q4 | $2.27M | Buy |
49,235
+48,396
| +5,768% | +$2.24M | ﹤0.01% | 2546 |
|
|
2020
Q3 | $30K | Sell |
839
-6,116
| -88% | -$219K | ﹤0.01% | 5134 |
|
|
2020
Q2 | $169K | Buy |
6,955
+4,598
| +195% | +$112K | ﹤0.01% | 4116 |
|
|
2020
Q1 | $37K | Buy |
2,357
+1,281
| +119% | +$20.1K | ﹤0.01% | 5174 |
|
|
2019
Q4 | $17K | Buy |
+1,076
| New | +$17K | ﹤0.01% | 5919 |
|